Gainers
Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in DRP-selected metastatic breast cancer patients.
Companies Reporting Before The Bell
• Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter.
• Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.
LightPath Technologies, Inc. (NASDAQ:LPTH), ("LightPath" or the "Company"), a leading vertically integrated global manufacturer and integrator of proprietary optical and infrared technologies,
Companies Reporting Before The Bell
• AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.